Dose-Escalation Study on Safety and Immunogenicity of VPM1002 in Comparison With BCG in Healthy Male Volunteers
This study has been completed.
Sponsor:
Vakzine Projekt Management GmbH
Information provided by:
Vakzine Projekt Management GmbH
ClinicalTrials.gov Identifier:
NCT00749034
First received: September 5, 2008
Last updated: May 19, 2010
Last verified: April 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | December 2009 |
| Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |